Andrew Alin has a broad-based mergers and acquisitions and general corporate practice. He represents financial institutions and other strategic parties, as well as private equity sponsors and hedge funds, in public company mergers (both solicited and unsolicited), asset sales, subsidiary carve-outs, corporate governance matters, recapitalizations and other complex transactions. He also regularly advises investment banks providing fairness opinions in mergers and acquisitions transactions.
Andy received his J.D., cum laude, from University of Pennsylvania Law School, and a B.A., magna cum laude, from University of Pennsylvania. He is admitted to practice in the State of New York. Andy is an author of “specialty Finance Mergers and Acquisitions: Developments and Considerations,” which appeared in The M&A Lawyer, May 2013.
Andy has advised clients on several high-profile transactions, including:
•salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International, Inc.;
• Acorda Therapeutics, Inc. in its acquisition of Civitas Therapeutics, Inc.;
• Endurance Specialty Holdings Ltd. in its proposed $3.2 billion acquisition of Apen Insurance Holdings Limited;
• A consortium consisting of WL Ross & Co. LLC, The Blackstone Group, The Carlyle Group, Centerbridge Capital Partners, other investors and a management team led by John Kanas in their $900 million acquisition of the banking operations of BankUnited, FSB in an auction by the FDIC, as receiver. This deal was named “ Private Equity Deal of the Year” 2009 by International Financial Law Review;
• BankUnited, Inc. in several transactions, including its $900 million initial public offering, the then-largest U.S. bank IPO in history; its pending acquisition of the Small Business Finance Unit of CertusHoldings; its acquisition of Herald National Bank; and its acquisitions of its municipal finance and commercial leasing platforms from Koch Financial Corporation and Butler Capital Corporation, respectively;
• Massachusetts Mutual Life Insurance Company in its $400 million acquisition of the retirement plans business of The Hartford Financial Services Group, Inc. (named 2012 “ Deal of the Year” at the 20th Annual Mutual Fund Industry Awards);
• The Blackstone Group in its $277 million acquisition of a controlling equity stake in Exeter Finance; and its acquisition of Lendmark Financial Services Inc., a consumer lending business, from BB&T Corporation;
• EverBank in several transactions, including its acquisition of Tygris Commercial Finance Group;
• Hamilton Insurance Group, Ltd. in its acquisition of S.A.C. Re, Ltd., as well as its initial formation and capitalization;
• WL Ross & Co. LLC as lead investor in the recapitalization of several banking organizations, including First Michigan Bancorp, Inc.; Sun Bancorp, Inc.; Cascade Bancorp; and Amalgamated Bank;
• A consortium of private equity investors including affiliates of Oaktree Capital Management L.P., Pine Brook Road Partners, LLC and Stone Point Capital LLC in the organization of AloStar Bank of Commerce and its simultaneous acquisition of the operations of Nexity Bank from the FDIC;
• Ford Financial Fund, L.P. in its $500 million acquisition of a 91 percent equity stake in Pacific Capital Bancorp;
• The Bear Stearns Companies Inc. in its $1.2 billion merger with JPMorgan Chase & Co.;
• Lone Star Funds in its $1.5 billion acquisition of the home lending business of CIT Group Inc.;
• Fremont General Corporation in the $1.9 billion sale of its commercial real estate lending business and related loan portfolio to iStar Financial Inc.; and
• Refco Inc. and its subsidiaries in the $323 million sale of Refco's global regulated futures brokerage business to Man Financial, Inc. in a bankruptcy auction.
Andy's experience advising investment banks includes:
• Morgan Stanley & Co. Incorporated as financial advisor to The South Financial Group, Inc., a bank holding company, in its $192 million acquisition by TD Bank Financial Group;
• Keefe, Bruyette & Woods, Inc. as financial advisor in numerous transactions, including to Flagstar Bancorp, Inc. in a $250 million investment by MatlinPatterson Global Advisers LLC, a private equity firm, and to Bank of Granite Corp. in its acquisition by FNB United Corp.;
• UBS Investment Bank and Goldman, Sachs & Co. as financial advisors to Nationwide Mutual Insurance Company in its $2.4 billion acquisition of the remaining minority stake in Nationwide Financial Services, Inc. that it did not already own;
• Goldman, Sachs & Co. as financial advisor to The Bank of New York Company, Inc. in its $16.5 billion merger with Mellon Financial Corporation; and to AmSouth Bancorporation in its $10 billion merger with Regions Financial Corporation; and
• Deutsche Bank Securities Inc. as financial advisor to New York Life Insurance Company in the sale of its insurance operations in Hong Kong and South Korea to ACE Limited and its insurance joint venture in Thailand to Siam Commercial Bank Public Company Limited.
News & Resources
• Cadwalader Represents Salix Pharmaceuticals in Its Acquisition by Valeant Pharmaceuticals Apr 01, 2015